If weight loss with drugs that must be self-injected weekly doesn’t sound appealing — think Ozempic, Wegovy and Zepbound — there may be an intriguing new option available down the road. It's “the ...
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that the Somerset NHS Foundation Trust (FT) is the first NHS trust in ...
The Company plans to submit the fourth and final module of the Pre-Market Approval application to the FDA. Topline data were announced from the AUDACITY trial evaluating the Allurion Gastric Balloon, ...
If weight loss with drugs that must be self-injected weekly doesn’t sound appealing — think Ozempic, Wegovy and Zepbound — there may be an intriguing new option available down the road. It's “the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback